Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02386826 |
| Title | INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute at HealthONE | Denver | Colorado | 80218 | United States | Details | |
| Yale School of Medicine | New Haven | Connecticut | 06520 | United States | Details | |
| HCA Midwest - Kansas City | Kansas City | Missouri | 64132 | United States | Details | |
| Oklahoma University Health Science Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details |